The proportion of participants who seroconverted ( i.e. had @-folds or higher rise in reciprocal titre ) in the vaccine group were @ % ( @ % CI : @ % -@ % ) at both @ days ( i.e. after @st dose ) and @ days ( i.e. after @nd dose ) .